Age, Biography and Wiki
Phyllis Gardner was born on 7 July, 1950. Discover Phyllis Gardner's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is She in this year and how She spends money? Also learn how She earned most of networth at the age of 74 years old?
Popular As |
N/A |
Occupation |
N/A |
Age |
74 years old |
Zodiac Sign |
Cancer |
Born |
7 July, 1950 |
Birthday |
7 July |
Birthplace |
N/A |
Nationality |
|
We recommend you to check the complete list of Famous People born on 7 July.
She is a member of famous with the age 74 years old group.
Phyllis Gardner Height, Weight & Measurements
At 74 years old, Phyllis Gardner height not available right now. We will update Phyllis Gardner's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.
Family |
Parents |
Not Available |
Husband |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Phyllis Gardner Net Worth
Her net worth has been growing significantly in 2022-2023. So, how much is Phyllis Gardner worth at the age of 74 years old? Phyllis Gardner’s income source is mostly from being a successful . She is from . We have estimated
Phyllis Gardner's net worth
, money, salary, income, and assets.
Net Worth in 2023 |
$1 Million - $5 Million |
Salary in 2023 |
Under Review |
Net Worth in 2022 |
Pending |
Salary in 2022 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
|
Phyllis Gardner Social Network
Timeline
In 2002 Elizabeth Holmes visited Gardner at Stanford University. Holmes proposed her idea for a microfluidic device that could detect and treat infectious diseases. Gardner was critical of the proposal, explaining that it is not possible to use antibiotics on such a small scale. Holmes dropped out of Stanford a few months later, but Gardner followed the evolution of Theranos. Very briefly, both served on the Harvard Medical School Board of Fellows after Holmes was given an invitation to join. Gardner did not permit Holmes to visit the Stanford campus and called for her to be sent to prison.
After spending ten years in academia, Gardner became interested in research and development and entrepreneurship. She developed several forms of slow released medication, including an adaptation for retention in the stomach. Gardner has been involved with several start-ups in the biotechnology and pharmaceutical industries. From 1996 to 1998 Gardner served as Vice President of Research and Head of the Technology Institute at the Alza Corporation. Gardner served as Director of the biopharmaceutical company Revance Therapeutics from 2007 to 2018. She is an adjunct partner at Essex Woodlands Health Ventures. She founded several companies, including the Genomics Collaborative, SKOLAR and the CambriaTech Holding Co. She was appointed to the Board Of Directors of Ventaira Pharmaceuticals in 2006. Gardner serves on the Board of Fellows of the Harvard Medical School. She was appointed to the Board of Directors of CohBar, a clinical stage biotechnology company, in 2019.
Gardner joined Stanford University in 1984. Gardner works on cardiac arrhythmias and cystic fibrosis pathogenesis. In 1998 Gardner was appointed Senior Associate Dean for Education and Student Affairs at Stanford University. She is a Professor of Clinical Pharmacology. She led a laboratory that focused on ion channel biophysics.
Gardner completed her bachelor's degree at the University of Illinois, where she specialised in biology. She studied at Harvard University Medical School and graduated in 1976. She has held a license to practise medicine in California since 1979. She completed research fellowships at Columbia University and University College London. She was a postdoctoral fellow at University College London in 1982. Gardner trained in internal medicine at the Massachusetts General Hospital. She was a Chief Resident at the Stanford School of Medicine. In 2002 Gardner argued for a merger of University College London and Imperial College London.
Phyllis I. Gardner (born July 7, 1950) is a Professor of Medicine at the Stanford University School of Medicine. She has previously served as Dean of Education. Gardner was one of the first people to be skeptical of Elizabeth Holmes, the founder of Theranos.